Literature DB >> 14253482

A NEW CLASS OF HUMAN IMMUNOGLOBULINS. I. A UNIQUE MYELOMA PROTEIN.

D S ROWE, J L FAHEY.   

Abstract

The unique myeloma protein from S. J., a patient with multiple myeloma, was isolated and characterized. It resembled other myeloma proteins in many respects. The S. J. myeloma protein migrated in a distinct peak in the slow beta-globulin region on zone electrophoresis, appeared as a single band on starch gel electrophoresis, and sedimented at 7.04S in the ultracentrifuge. Papain and cysteine treatment produced Fc (fast) and Fab (slow) fragments. Reduction and alkylation of the myeloma protein produced heavy and light chains in a ratio of approximately 3:1. The S. J. myeloma protein had type L (type II) light chains. These were antigenically similar to the Bence Jones protein also found in this patient. The S. J. myeloma protein was unique in the properties of its heavy chains. The myeloma protein (and its heavy chains and Fc pieces) did not contain antigenic determinants specific for IgG, IgA, or IgM. The myeloma protein (and its heavy chains), however, did contain antigenic determinants which are characteristic of a new class of immunoglobulin. The S. J. myeloma protein was unusual also in its effect on the metabolism of normal IgG and in the electrophoretic mobility of the Fc fragment produced by papain digestion. No evidence was obtained to indicate that the entire heavy polypeptide of the S. J. protein was a grossly abnormal product of malignant cell metabolism. The unique properties of the S. J. myeloma protein (and its heavy chains) are believed to represent, in large measure, properties to be found in a small part of the normal immunoglobulin population.

Entities:  

Keywords:  BETA GLOBULIN; CHROMATOGRAPHY; CYSTEINE; GAMMA GLOBULIN; IMMUNOELECTROPHORESIS; MULTIPLE MYELOMA; NEOPLASM PROTEINS; PAPAIN; PHARMACOLOGY; RABBITS; ULTRACENTRIFUGATION

Mesh:

Substances:

Year:  1965        PMID: 14253482      PMCID: PMC2137973          DOI: 10.1084/jem.121.1.171

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  STRUCTURAL BASIS FOR THE DIFFERENCES BETWEEN TYPE I AND TYPE II HUMAN GAMMA-GLOBULIN MOLECULES.

Authors:  J L FAHEY
Journal:  J Immunol       Date:  1963-10       Impact factor: 5.422

2.  CONTRIBUTION OF GAMMA-GLOBULIN SUBUNITS TO ELECTROPHORETIC HETEROGENEITY: IDENTIFICATION OF A DISTINCTIVE GROUP OF 6.6S GAMMA-MYELOMA PROTEINS.

Authors:  J L FAHEY
Journal:  Immunochemistry       Date:  1964-06

3.  Antigenic specificity of gamma2-myeloma globulins.

Authors:  L KORNGOLD
Journal:  J Natl Cancer Inst       Date:  1963-03       Impact factor: 13.506

4.  Reduction of gamma-globulins.

Authors:  J B FLEISCHMAN; R H PAIN; R R PORTER
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

5.  Comparison of reduced alkylated derivatives of some myeloma globulins and Bence-Jones proteins.

Authors:  M D POULIK; G M EDELMAN
Journal:  Nature       Date:  1961-09-23       Impact factor: 49.962

6.  ANTIGENIC RELATIONSHIPS BETWEEN IMMUNE GLOBULINS AND CERTAIN RELATED PARAPROTEINS IN MAN.

Authors:  E C Franklin; D R Stanworth
Journal:  J Exp Med       Date:  1961-09-30       Impact factor: 14.307

7.  RECONSTITUTION OF 7S MOLECULES FROM L AND H POLYPEPTIDE CHAINS OF ANTIBODIES AND GAMMA-GLOBULINS.

Authors:  D E OLINS; G M EDELMAN
Journal:  J Exp Med       Date:  1964-05-01       Impact factor: 14.307

8.  H CHAIN SUBGROUPS OF MYELOMA PROTEINS AND NORMAL 7S GAMMA-GLOBULIN.

Authors:  H M GREY; H G KUNKEL
Journal:  J Exp Med       Date:  1964-08-01       Impact factor: 14.307

9.  A NEW CLASS OF HUMAN IMMUNOGLOBULINS. II. NORMAL SERUM IGD.

Authors:  D S ROWE; J L FAHEY
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

10.  Enzymatically produced subunits of proteins formed by plasma cells in mice. II. beta2a-Myeloma protein and Bence Jones protein.

Authors:  B A ASKONAS; J L FAHEY
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

View more
  70 in total

Review 1.  Immunoglobulin D: properties, measurement, and clinical relevance.

Authors:  A O Vladutiu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Molecular characterization of immunoglobulin D in mammals: immunoglobulin heavy constant delta genes in dogs, chimpanzees and four old world monkey species.

Authors:  Kenneth A Rogers; Jennifer P Richardson; Franco Scinicariello; Roberta Attanasio
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 3.  New insights into the enigma of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

Review 4.  The enigmatic function of IgD: some answers at last.

Authors:  Cindy Gutzeit; Kang Chen; Andrea Cerutti
Journal:  Eur J Immunol       Date:  2018-06-12       Impact factor: 5.532

5.  IgD, like IgM, is a primordial immunoglobulin class perpetuated in most jawed vertebrates.

Authors:  Yuko Ohta; Martin Flajnik
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

6.  IgD myeloma: a case report.

Authors:  J Toth
Journal:  Can Med Assoc J       Date:  1977-06-04       Impact factor: 8.262

7.  Late relapse in IgD myeloma: value of immunohistochemistry in trephine biopsy specimens.

Authors:  P Kettle; T C Morris
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

8.  Immunoglobulin D in rat serum, saliva and milk.

Authors:  M G Steele; G A Leslie
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

9.  Genes of the constant regions of functional immunoglobulin heavy chain of Japanese flounder, Paralichthys olivaceus.

Authors:  Prapansak Srisapoome; Tsuyoshi Ohira; Ikuo Hirono; Takashi Aoki
Journal:  Immunogenetics       Date:  2004-07-08       Impact factor: 2.846

10.  Serum IgD and IgE concentrations in immunodeficiency diseases.

Authors:  R H Buckley; S A Fiscus
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.